Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SI-6603 open-label phase III study in lumbar disc herniation
2014-001449-26Phase 3Completed
- Sponsor
- Seikagaku Corporation
- Start
- Nov 2014
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of condoliase in Herniated Lumbar Disk and Bulging Disc, sponsored by Seikagaku Corporation. Primary endpoint: Safety endpoints. Started Nov 2014; status: completed.
02
Drugs
condoliase
03
Conditions
Herniated Lumbar DiskBulging Disc
Beyond the preview
Go deeper on 2014-001449-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001449-26.